Form D · Pharmaceuticals
Flex Biomedical, Inc.
Madison, WI · CIK 0001465854
Offering snapshot reported Jun 20, 2012 · SEC filing
- Reported sold
- $882K Offering amount: $1M
- Investors reported
- 13 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 4, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 20, 2012 | Initial | $881,668 | No comparison | 13 | SEC filing |
| Nov 3, 2010 | Initial | $694,101 | No comparison | 8 | SEC filing |
| Jun 15, 2009 | Initial | $812,000 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-180038
Source: Form D, filed Jun 20, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Salvatore P. Braico | Director, Executive |
| Mark Grinstaff | Director |
| Nicholas E. Mischler, Md | Director |
| Steven R. Pollock, R Ph, Mba | Director |
| David C. Sneider | Director |
| Hideki Suzuki, Ph D | Executive |
| Donald Urbanowicz | Director |
| Michael Wathier, Ph D | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
555 D'onofrio Drive, Suite 102
Madison, WI, 53719
Madison, WI, 53719